Last reviewed · How we verify

NCT05251415: ESSAi

Clinico-biological Collection to Investigate the Physiopathology of Systemic Autoimmune Diseases

Recruiting now Last updated 17 March 2026
What this trial tests

trial testing Blood sampling in Lupus Erythematosus in 3,000 participants. Currently enrolling.

Timeline
4 April 2022
Primary endpoint
4 April 2027
4 April 2032

Quick facts

Lead sponsorUniversity Hospital, Toulouse
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment3,000
Start date4 April 2022
Primary completion4 April 2027
Estimated completion4 April 2032
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Toulouse

Who can join

Adults 6 to 99, any sex, with Lupus Erythematosus or Scleroderma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this project is to start a biological and clinical collection of patients presenting systemic autoimmune disease. This collection will provide appropriate biological samples to identify new biomarkers and to be accessible to the medical, scientific and industrial communities for the identification of new therapeutic strategies

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Blood sampling

Trials testing the same drug.

Other recruiting trials for Lupus Erythematosus

Currently open trials in the same condition.

Other University Hospital, Toulouse trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05251415.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing